Baxter International Inc (BAX)
36.32
+1.24
(+3.53%)
USD |
NYSE |
Oct 04, 16:00
36.26
-0.06
(-0.17%)
Pre-Market: 20:00
Baxter International Shareholders Equity (Annual): 8.402B for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 8.402B |
December 31, 2022 | 5.833B |
December 31, 2021 | 9.077B |
December 31, 2020 | 8.689B |
December 31, 2019 | 7.882B |
December 31, 2018 | 7.844B |
December 31, 2017 | 9.124B |
December 31, 2016 | 8.29B |
December 31, 2015 | 8.846B |
December 31, 2014 | 8.12B |
December 31, 2013 | 8.463B |
December 31, 2012 | 6.938B |
December 31, 2011 | 6.585B |
December 31, 2010 | 6.567B |
December 31, 2009 | 7.191B |
December 31, 2008 | 6.229B |
December 31, 2007 | 6.916B |
December 31, 2006 | 6.272B |
December 31, 2005 | 4.299B |
December 31, 2004 | 3.705B |
Date | Value |
---|---|
December 31, 2003 | 3.274B |
December 31, 2002 | 2.939B |
December 31, 2001 | 3.757B |
December 31, 2000 | 2.659B |
December 31, 1999 | 3.348B |
December 31, 1998 | 2.839B |
December 31, 1997 | 2.619B |
December 31, 1996 | 2.504B |
December 31, 1995 | 3.704B |
December 31, 1994 | 3.72B |
December 31, 1993 | 3.185B |
December 31, 1992 | 3.795B |
December 31, 1991 | 4.373B |
December 31, 1990 | 4.092B |
December 31, 1989 | 4.246B |
December 31, 1988 | 3.096B |
December 31, 1987 | 2.833B |
December 31, 1986 | 2.49B |
December 31, 1985 | 2.082B |
December 31, 1984 | 1.107B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
5.833B
Minimum
2022
9.077B
Maximum
2021
7.977B
Average
8.402B
Median
2023
Shareholders Equity (Annual) Benchmarks
Boston Scientific Corp | 19.28B |
Haemonetics Corp | 959.96M |
Masimo Corp | 1.365B |
Accuray Inc | 45.08M |
Insulet Corp | 732.70M |